TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05871203

Intervention type: OTHER
Intervention: Gene sequencing
Description: Participants were taken blood samples for gene sequencing at three time periods: before, after, and 24 hours after the end of the surgery

Intervention type: OTHER
Intervention: Gene sequencing
Description: Participants were taken blood samples for gene sequencing at three time periods: before, after, and 24 hours after the end of the surgery
Study: NCT05773391

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Take probiotics
Description: Take medication for 21 days (Yihuo 0.2g bid+ Jin Bifid2g tid)
Study: NCT05207150

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LINQII/Apple Watch Series 6
Description: LINQ II will be implanted and in the first 3 months it will send alerts to participants' smartphones if it detects an AF episode longer than 30 minutes. After 3 months, participants will wear an Apple Watch Series 6 for another 3 months. The LINQ II ICM will continue to detect and record AF episodes and will be used to validate the AF detection accuracy by the wearable devices but it will no longer send alerts during AF episodes. Instead, the wearable device (Apple Watch) will send a real-time alert to participants during AF episodes longer than 30 minutes and participants will use the appropriate smartphone app to acknowledge they have received the alert.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LINQII/SkyLabs CART-I ring
Description: LINQ II will be implanted and in the first 3 months it will send alerts to participants' smartphones if it detects an AF episode longer than 30 minutes. After 3 months, participants will wear a SkyLabs CART-I ring for another 3 months. The LINQ II ICM will continue to detect and record AF episodes and will be used to validate the AF detection accuracy by the wearable devices but it will no longer send alerts during AF episodes. Instead, the wearable device (CART-I ring) will send a real-time alert to participants during AF episodes longer than 30 minutes and participants will use the appropriate smartphone app to acknowledge they have received the alert.
Study: NCT04899648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention Group
Description: Behavioral intervention: (a) form groups and choose peer leaders; (b) train peer leaders on 16 core classes based on diabetes prevention program curriculum; (c) support and motivate peer leaders to lead intervention in their group; (d) monitoring of the interventions.
Study: NCT05447793

Intervention type: DEVICE
Intervention: Fitostimoline plus
Description: Formulation in gauzes and cream

Intervention type: DEVICE
Intervention: Connettivina bio plus
Description: Formulation in gauzes and cream

Intervention type: DEVICE
Intervention: Connettivina bio plus
Description: Formulation in gauzes and cream
Study: NCT06532942

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Part A) MKND-201
Description: Participants will receive single ascending doses (Target Dose, High Dose, and Very High Dose) of MKND-201 or placebo administered via oral inhalation on Day 1

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo across Part A and Part B of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Part B) MKND-201
Description: Participants will receive multiple ascending doses (Target Dose and High Dose) of MKND-201 or placebo administered via oral inhalation, twice daily, from Day 1 to Day 7
Study: NCT05065112

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulmonary veins isolation + Cartofinder-guided ablation
Description: The individualised mapping with Cartofinder intends to identify areas with the repetitive atrial activation patterns which are targeted with focal or linear ablation anchored on at least one end in an anatomical or electrical barrier.
Study: NCT06537193

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT
Description: CT will be performed by obtaining dynamic phases (precontrast phase, arterial phase, portal venous phase, and delayed phase images). Subjects will receive intravenous injection of iodine contrast media. Scan coverage was from the basal lung to the iliac crest or pelvis.
Study: NCT05215535

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Abbreviated MRI of the liver/abdomen
Description: The MRI examinations of the liver/abdomen will be performed at the same time as the pelvic MRI. A 1,5 T scanner will be used together with a dedicated torso/abdominal coil. An abbreviated MRI liver protocol includes 3 different sequences as follows:~1. Axial T2-weighted respiratory triggered sequence with 5 mm slice thickness.~2. Axial diffusion weighted spin echo respiratory triggered sequence with fatsat with b-factors 50/800 s/mm2 and ADC calculation maps, 5 mm slice thickness~3. An axial breath-hold 3D T1-weighted gradient echo with fatsat with 4 mm slice thickness, gap 2 mm, contrast enhanced venous phase and in a 3 min equilibrium phase, using regular i.v bolus injection of gadolinium contrast medium with standard clinical dose.
Study: NCT05141487

Intervention type: DEVICE
Intervention: UroMonitor
Description: The UroMonitor is small wireless sensor that is temporarily inserted into the bladder. While in the bladder it transmits bladder pressure measurements to an external radio. After a short period of use it is removed using an extraction string and discarded.
Study: NCT05664698

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SKILLS-ER
Description: The intervention (SKILLS-ER) has been developed by the research group, and aims to increase a participant's emotion regulation capacity by targeting different stages of the emotion regulation process proposed by the extended process model of emotion, i.e. identification, selection, implementation and monitoring (Sheppes, Suri \& Gross, 2015). SKILLS-ER will comprise of eight sessions and include identification and differentiation of emotions, tolerance/acceptance of emotions, education of different regulatory skills, as well as on how to select, implement and monitor strategies. Sessions will take place at the Uppsala child- and adolescent psychiatry outpatient unit and consist of activating and experiential exercises administered by a clinical psychologist. Participants will gain access to internet-delivered material, such as homework assignments in-between sessions. SKILLS-ER will be delivered individually to the participants, where their parents will be involved in some sessions.
Study: NCT06238960

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: the patient will undergo 10 session of tele rehabilitation in continuity with traditional physiotherapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional rehabilitation
Description: the patient will undergo 16 session of outpatient physiotherapy rehabilitation
Study: NCT05065112

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary veins isolation
Description: Wide area circumferential pulmonary veins isolation
Study: NCT05244772

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote monitoring
Description: Remote monitoring with a smartphone application of pain and nausea after day care surgery
Study: NCT05215535

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Combined single venous and 3 min equilibrium phase CT of the abdomen/liver
Description: The CT examination of the liver will be performed as a combined examination in a single venous phase starting with the thoracic region directly followed by the abdomen down to the pelvis. An additional 3 min equilibrium phase of the liver only will end the examination. Regular iodinated low-osmolar non-ionic contrast media will be used of 350 mg I/ml using a power injector, 2-4 ml/s, 100-150 ml dependent on patient weight and kidney function. Reconstructed images in axial, coronal and sagittal plane will be performed.
Study: NCT06138821

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ESG + lifestyle modification
Description: Endoscopic sleeve gastroplasty - an endoscopic weight loss procedure where an endoscopic suturing device is utilized to reduce the size of the stomach by 70%.
Study: NCT05141487

Intervention type: DEVICE
Intervention: ASCU
Description: The ASCU is a wearable nerve stimulator containing a radio and computer processor. It receives pressure information from the bladder and determines when to turn on sacral nerve stimulation. It is only used temporarily during research visits.
Study: NCT05826132

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adjusted Content Intervention
Description: 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, using language that speaks to the specific experience of being a young Latina woman

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Adjusted Intervention Video
Description: 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, without any language alluding to her particular identity characteristics
Study: NCT04687631

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI plus Cetuximab
Description: cetuximab 500mg/m2 + oxaliplatin 85 mg/m2 + irinotecan 165 mg/m2 + folinic acid 400 mg/m2 + 5-fluorouracil 2400 mg/m2 46h infusion starting on day 1, every 2 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI Plus Bevacizumab
Description: bevacizumab 5mg/kg + oxaliplatin 85 mg/m2 + irinotecan 165 mg/m2 + folinic acid 400 mg/m2 + 5-fluorouracil 2400 mg/m2 46h infusion starting on day 1, every 2 weeks
Study: NCT06138821

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Description: Lifestyle modification program consisting of diet and exercise therapy

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle modification
Description: Lifestyle modification program consisting of diet and exercise therapy
Study: NCT06646848

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibration
Description: The vibration device was placed on the infant's left extremity in the mid/lateral region just below the knee where the sural nerve passes. The device was secured to the extremity with a gauze bandage. The vibration device was operated for 30 seconds with reference to previous studies. While the vibration continued, the nurse punctured the heel with a needle. Then, the vibration device continued to work in the waiting phase for 10 seconds. The vibration device was removed from the infants's extremity and routine heel blood collection procedure was performed.
Study: NCT04935164

Intervention type: OTHER
Intervention: Psychiatric evaluations
Description: At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes

Intervention type: OTHER
Intervention: Psychiatric evaluations
Description: At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes

Intervention type: OTHER
Intervention: Psychiatric evaluations
Description: At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes

Intervention type: OTHER
Intervention: Psychiatric evaluations
Description: At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes
Study: NCT06044870

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified laterally stretched technique with a connective tissue graft.
Description: Modified laterally stretched technique with a connective tissue graft.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified laterally stretched technique with a connective tissue graft.
Description: Modified laterally stretched technique with a connective tissue graft.
Study: NCT06646848

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heel Warming
Description: The heel warning group will warm the heel of the infants using a hot thermal bag 3-5 minutes before the application. Then, the thermal bag will be removed and the nurse will take the heel blood.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shotblocker
Description: The protruding surface of the Shotblocker was placed on the heel lance procedure site. While applying pressure on the skin through the Shotblocker, the nurse performed heel lancing with the needle through the opening in the center of the Shotblocker. During the 10-second waiting phase, the Shotblocker was kept at the procedure site with the same pressure. Then Shotblocker was removed from the skin and routine capillary heel collection procedure was performed.
Study: NCT06513884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB-202/HB-201 alternating 2-vector therapy
Description: Intravenous administration of HB-202 alternating with HB-201, with the first 2 treatment cycles administered every 3 weeks and then every 6 weeks from the third treatment cycle onwards.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous administration of matched placebo for HB-202 alternating with matched placebo for HB-201, with the first 2 treatment cycles administered every 3 weeks and then every 6 weeks from the third treatment cycle onwards.
Study: NCT06555913

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maitland Mobilization
Description: MM applies a passive oscillatory technique, classified from Grade I-IV with respect to intensity, to the shoulder in order to treat pain and stiffness.~Grade I refers to an intensity of small amplitude that is applied at the beginning of the joint ROM, where there is no loading on connective tissue; it is often used in cases of severe pain

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maitland Mobilization
Description: MM applies a passive oscillatory technique, classified from Grade I-IV with respect to intensity, to the shoulder in order to treat pain and stiffness.~Grade I refers to an intensity of small amplitude that is applied at the beginning of the joint ROM, where there is no loading on connective tissue; it is often used in cases of severe pain

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular Stabilization
Description: Scapular stabilization exercises are thought to have an important role in improving pain and dysfunction in the shoulder. The concept that an unstable~scapula is associated with pathology and dysfunction of the shoulder is well accepted. The predominant theory emphasizes that for optimal function of the glenohumeral joint, the scapula must provide a stable base upon which upper extremity tasks are completed. Impaired scapular stability increases the risk for pathologies such as impingement or rotator cuff tears

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular Stabilization
Description: Scapular stabilization exercises are thought to have an important role in improving pain and dysfunction in the shoulder. The concept that an unstable~scapula is associated with pathology and dysfunction of the shoulder is well accepted. The predominant theory emphasizes that for optimal function of the glenohumeral joint, the scapula must provide a stable base upon which upper extremity tasks are completed. Impaired scapular stability increases the risk for pathologies such as impingement or rotator cuff tears

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: ROM exercises, stretching exercises and strengthening exercises for shoulder muscles

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: ROM exercises, stretching exercises and strengthening exercises for shoulder muscles

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: ROM exercises, stretching exercises and strengthening exercises for shoulder muscles
Study: NCT06560853

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comprehensive School Health Programme
Description: Combination intervention which consists of:~* Upgrading sanitation facilities and constructing a 'health room' in the school~* Health teacher training: 5-10 teachers per school are recruited and trained for two weeks to become School Health Workers (SHWs) by Healthy Learners~* The SHWs: (1) deliver education on health and good sanitation and hygiene (2) coordinate with local clinics to deliver preventive care (e.g. school deworming and vitamin A supplementation); (3) assess sick students in the health room with a tablet-based clinical decision support system (CDSS); (4) treat sick students in the health room for some conditions (malaria, diarrhoea, schistosomiasis, pneumonia, conjunctivitis) or (5) refer to the health facility for treatment; (6) monitor absence of learners~* Referral: learners referred by SHWs are given a referral form by the SHW, which contains information about symptoms and suggested diagnosis by the CDSS. The learners are prioritised in the local clinic.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deworming and vitamin A supplementation delivery
Description: Schools implement the government policy of distributing deworming drugs and vitamin A supplementation to learners twice a year. Additional support from Healthy Learners ensures reliable delivery.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deworming and vitamin A supplementation delivery
Description: Schools implement the government policy of distributing deworming drugs and vitamin A supplementation to learners twice a year. Additional support from Healthy Learners ensures reliable delivery.
Study: NCT05895383

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Description: Nitrous oxide administered at concentrations of minimal sedation (0-50%). Participants will be able to adjust the level of gas throughout the vasectomy using a handheld remote control.
Study: NCT06513884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous administration of pembrolizumab, with the first 2 treatment cycles administered at a dosage of 200 mg every 3 weeks and then every 6 weeks from the third treatment cycle onwards administered at a dosage of 400 mg.
Study: NCT05363176

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy for Treatment Seeking
Description: CBT delivered over the course of 1, \~45 minute sessions delivered via telehealth.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pain treatment education
Description: Pain treatment education describes a variety of pain treatments offered in the VA. It is delivered over the course of 1, \~45 minute session delivered via telehealth
Study: NCT06306703

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group1, group2, group 3
Description: to teaching with verbal instruction to teaching with digital vaginal palpation to teaching with perineometer

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group1, group2, group 3
Description: to teaching with verbal instruction to teaching with digital vaginal palpation to teaching with perineometer

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group1, group2, group 3
Description: to teaching with verbal instruction to teaching with digital vaginal palpation to teaching with perineometer
Study: NCT06302036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EFT
Description: EFT
Study: NCT06513884

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pembrolizumab
Description: Intravenous administration of pembrolizumab, with the first 2 treatment cycles administered at a dosage of 200 mg every 3 weeks and then every 6 weeks from the third treatment cycle onwards administered at a dosage of 400 mg.
Study: NCT05792839

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Abdominoplasty with ventral hernia repair versus ventral hernioplasty.
Description: We do surgical treatment for ventral hernia in the form of hernioplasty with surgical mesh placement or by means of abdominoplasty surgical technique.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Abdominoplasty with ventral hernia repair versus ventral hernioplasty.
Description: We do surgical treatment for ventral hernia in the form of hernioplasty with surgical mesh placement or by means of abdominoplasty surgical technique.
Study: NCT06279039

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exosome liquid dressing
Description: This study mainly adopted a randomized double-blind self-half face control method. The double-blind method was that the subjects and researchers did not know the experimental group and the control group. 38 sets of matched use sets (left and right, only the manufacturer knew the specific ingredients) were respectively applied to both sides of the cheeks of patients after Q-switched laser. The blind was unblinded after the experiment.
Study: NCT04948905

Intervention type: OTHER
Intervention: Evaluation using the Self-Defining Memory Questionnaire
Description: This questionnaire consists of 3 pages. Page 1 gives a clear, concise definition of a memory that defines the self. This enlightens the subject on what is expected and helps him/her consider the phenomenological characteristics of the Self-Defining Memory. Page 2 recalls the 6 essential characteristics of the Self-Defining Memory. Page 3 allows the practical application of what has been understood about the questionnaire. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.~Participants must then use the same scale to indicate the vividness and importance of the memory.~They must also note the approximate number of years ago the memory took place (to the nearest whole number).

Intervention type: OTHER
Intervention: Evaluation using the Self-Defining Memory Questionnaire
Description: This questionnaire consists of 3 pages. Page 1 gives a clear, concise definition of a memory that defines the self. This enlightens the subject on what is expected and helps him/her consider the phenomenological characteristics of the Self-Defining Memory. Page 2 recalls the 6 essential characteristics of the Self-Defining Memory. Page 3 allows the practical application of what has been understood about the questionnaire. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.~Participants must then use the same scale to indicate the vividness and importance of the memory.~They must also note the approximate number of years ago the memory took place (to the nearest whole number).
Study: NCT05785611

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Filgotinib
Description: Tablets administered orally once daily